BIVTUO
Live / Allowed — Second extension granted (statement of use) (as of 28 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 16 Dec 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98906007
- Mark type
- Word mark
- Filed
- 16 Dec 2024
- Published for opposition
- 08 Jul 2025
- Attorney of record
- Andrea M. Porterfield
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents
Owner
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
- SUMMIT THERAPEUTICS SUB INC., Menlo Park, CA, US
Prosecution history
- 29 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Aug 2026 — SOU EXTENSION 2 GRANTED
- 28 Aug 2026 — SOU EXTENSION 2 FILED
- 28 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2026 — SOU EXTENSION 1 GRANTED
- 11 Feb 2026 — SOU EXTENSION 1 FILED
- 11 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Jun 2025 — ASSIGNED TO EXAMINER
- 17 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED